Macdonald, I. David,Harrison, Nancy,Takacs-Cox, Aniko,Purac, Admir,Blazek-Welsh, Almira
申请号：
AU2010277301
公开号：
AU2010277301B2
申请日:
2010.07.29
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The invention relates to compositions and methods to enhance the absorption of S- adenosylmethionine (SAMe) and to methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. The enhanced bioavailability formulations may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia； as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease.
